Romashko Alex A, Young M Rita I
Department of Otolaryngology, Loyola University Stritch School of Medicine, Maywood, Illinois, USA.
Clin Exp Metastasis. 2004;21(4):371-9. doi: 10.1023/b:clin.0000046178.08043.f8.
Studies assessed if the serine/threonine protein phosphatase-2A (PP-2A) maintains cytoskeletal integrity of normal keratinocytes and if this differs in malignant cells. Murine and human keratinocyte cell lines contained more PP-2A activity than did the murine SCC VII/SF squamous cell carcinoma cells or primary cultures of human head and neck squamous cell carcinoma (HNSCC) cells. Since tyrosine phosphorylation of the focal adhesion proteins paxillin and FAK is indicative of more stable focal adhesions, cells were immunostained for phosphotyrosine plus either paxillin or FAK, and then examined by confocal microscopy. In non-malignant keratinocytes, phosphotyrosine staining co-localized with paxillin and FAK. This co-localization occurred at the cell periphery in a pattern resembling focal adhesions. In contrast, the co-localization of phosphotyrosine with either paxillin or FAK along the cell periphery was almost absent in the SCC cells or in keratinocytes that were treated with okadaic acid to inhibit PP-2A activity. Consistent with this was a rounded cellular morphology with less extended processes as compared to control keratinocytes. These studies indicate PP-2A maintains the organization and tyrosine-phosphorylated state of the focal adhesion proteins FAK and paxillin, and that the loss of PP-2A activity results in a loss of cytoskeletal organization, as is seen in SCC.
研究评估了丝氨酸/苏氨酸蛋白磷酸酶2A(PP - 2A)是否维持正常角质形成细胞的细胞骨架完整性,以及在恶性细胞中这是否有所不同。小鼠和人类角质形成细胞系中的PP - 2A活性高于小鼠SCC VII/SF鳞状细胞癌细胞或人类头颈部鳞状细胞癌(HNSCC)细胞的原代培养物。由于粘着斑蛋白桩蛋白和黏着斑激酶的酪氨酸磷酸化表明粘着斑更稳定,因此对细胞进行磷酸酪氨酸加桩蛋白或黏着斑激酶的免疫染色,然后通过共聚焦显微镜检查。在非恶性角质形成细胞中,磷酸酪氨酸染色与桩蛋白和黏着斑激酶共定位。这种共定位发生在细胞周边,呈类似于粘着斑的模式。相比之下,在SCC细胞或用冈田酸处理以抑制PP - 2A活性的角质形成细胞中,磷酸酪氨酸与桩蛋白或黏着斑激酶沿细胞周边的共定位几乎不存在。与此一致的是,与对照角质形成细胞相比,细胞形态呈圆形,突起较少。这些研究表明PP - 2A维持粘着斑蛋白黏着斑激酶和桩蛋白的组织和酪氨酸磷酸化状态,并且PP - 2A活性的丧失导致细胞骨架组织的丧失,如在SCC中所见。